Large Inflow of Money Witnessed in Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation (NASDAQ:IART) had a weak trading session and its shares were last down at $76.02, down -0.08% or -0.11 points. The trading data also revealed that the total net flow stood at $1.76 million as the shares had $2.64 million in upticks but lost $0.88 million in downticks. The up/down ratio was 3. This data is particularly important for the traders and speculators alike as it could also be used to gauge the strength of the momentum in the shares. During the past week, the shares have seen a change of 0.45% in the shares.The block trade data suggests an inflow of $1.9 million in upticks and an outflow of $0 million in downticks. The up/down ratio for the block stood at 0. The net money flow for this transaction was recorded at $1.9.


The stock has recorded a 20-day Moving Average of 0.22% and the 50-Day Moving Average is 5.35%. The company shares have rallied 21.3% in the past 52 Weeks. On June 9, 2016 The shares registered one year high of $78.24 and one year low was seen on February 11, 2016 at $54.75. The 50-day moving average is $73.9 and the 200 day moving average is recorded at $66.52. S&P 500 has rallied 1.93% during the last 52-weeks.

Integra LifeSciences Holdings Corporation (NASDAQ:IART): The stock opened at $75.93 on Tuesday but the bulls could not build on the opening and the stock topped out at $76.65 for the day. The stock traded down to $75.26 during the day, due to lack of any buying support eventually closed down at $75.69 with a loss of -0.54% for the day. The stock had closed at $76.10 on the previous day. The total traded volume was 394,569 shares.

Currently the company Insiders own 22% of Integra LifeSciences Holdings Corporation shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -17% . Institutional Investors own 86.99% of Integra LifeSciences Holdings Corporation shares. During last six month period, the net percent change held by insiders has seen a change of -17%. On the companys insider trading activities, Sullivan James M, director of Integra Lifesciences Holdings Corp, unloaded 5,260 shares at an average price of $73.82 on May 31, 2016. The total amount of the transaction was worth $388,293, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.

Integra LifeSciences Holdings Corporation is a medical technology company. The Company offers solutions, such as orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. The Companys operating segments are: Specialty Surgical Solutions, and Orthopedics and Tissue Technologies. The Companys Specialty Surgical Solutions segment includes the Neurosurgery business and the Instruments business. The Companys Orthopedics and Tissue Technologies segment includes offerings, such as skin and wound repair, bone and joint fixation, implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The Company sources its handheld surgical instruments and specialty metal and pyrocarbon implants through third-party vendors. The Company manufactures its products in plants, which are located in the United States, Puerto Rico, France, Germany, Ireland and Mexico.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.